Mycenax Biotech Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 268.972 million compared to TWD 114.928 million a year ago. Operating income was TWD 82.167 million compared to operating loss of TWD 34.920 million a year ago. Net income was TWD 78.648 million compared to net loss of TWD 30.294 million a year ago. Basic earnings per share was TWD 0.62 compared to basic loss per share of TWD 0.24 a year ago. For the half year, sales was TWD 338.833 million compared to TWD 181.310 million a year ago. Operating income was TWD 56.244 million compared to operating loss of TWD 94.177 million a year ago. Net income was TWD 57.045 million compared to net loss of TWD 82.454 million a year ago. Basic earnings per share was TWD 0.45 compared to basic loss per share of TWD 0.67 a year ago.